Chemistry
Palladium
100%
Asymmetric Synthesis
88%
Ring Closing Metathesis
81%
Hydrogenation
60%
Alkene
54%
formation
50%
Cycloaddition
50%
Ring Opening Reaction
45%
Diol
45%
Carboxylic Acid
43%
Oxazoline
38%
Michael Addition
35%
Formate
34%
Cross Metathesis
33%
Triphenylphosphine
30%
Stereochemistry
30%
Aza-Michael Addition
30%
Enantioselectivity
28%
Allylation
28%
Ketones
28%
Isomerization
25%
Yamaguchi Esterification
25%
Michael Reaction
25%
Alkyne
25%
Aziridine
25%
Indole
24%
Acetal
22%
Hydrobromide
20%
Metathesis Reaction
20%
Sulfonamide
20%
Pericyclic Reaction
20%
cyclopropanation
20%
Tetrahydrofuran
20%
Isoindole
19%
Oxazolidinone
17%
aromaticity
17%
One Pot Reaction
16%
Mechanistic Study
16%
Diastereomer
15%
Piperidine
15%
Diastereoselectivity
15%
Chloroform
15%
Cyclopropane
15%
Enone
15%
Sulfur Ylide
15%
Benzyl Ether
15%
IC50
15%
Inositol
15%
Azide
15%
1,2,3-triazole
15%
Keyphrases
Asymmetric Synthesis
88%
Ring-closing Metathesis
67%
Palladium Catalysis
65%
Bortezomib
40%
CIP2A
40%
Cycloaddition
40%
Aryl
36%
Hydrogenation
36%
Aldehydes
35%
Apoptosis
35%
Formate
33%
Ring Opening
30%
Formal Synthesis
29%
Stereochemistry
27%
Enantioselectivity
25%
Isoindoline
25%
Triphenylphosphine
25%
Isoindole
25%
Phosphinooxazolines
25%
Carboxylic Acids
25%
Total Synthesis
25%
Triazole
25%
Aziridine
25%
Diastereoselective
25%
Allyl
24%
Mechanistic Studies
23%
Regioselectivity
23%
4-diol
23%
1,5-hexadiene
23%
Unsaturated Ketones
23%
Alkynes
23%
Hepatocellular Carcinoma
21%
1,2,3-triazole
21%
Esters
21%
Hepatocellular Carcinoma Cells
21%
Oxazoline
20%
Spiro
20%
Alkenes
20%
Mammalian Target of Rapamycin (mTOR)
20%
Asymmetric Hydrogenation
20%
Aryl Alkenes
20%
Pericosine
20%
Sulfonamides
20%
Thioesterification
20%
Cyclopropanation
20%
Autophagy
20%
Pericyclic Reactions
20%
Anticancer Activity
20%
Anti-addition
20%
Arenes
20%
